Wednesday, October 8, 2025

Latest

Khiron Life Sciences Conducts Bought Deal Financing For Gross Proceeds Of $10.0 Million

Khiron Life Sciences (TSXV: KHRN) announced that it is conducting at $10.0 bought deal private placement this morning. Lead by Canaccord Genuity, the financing will see units of the company sold at a price of $0.45 per unit.

A total of 22,250,000 units of the company are expected to be sold under the bought deal financing, with each unit comprising of one common share and one common share purchase warrant. Each warrant is valid for a period of five years, with an exercise price of $0.75 per share. A 15% over allotment option also exists on the financing for a period of 30 days, which if exercised would bring the total raise to $11.5 million.

Proceeds from the financing are to be used to expand the operating capacity of the company as well as for working capital and general corporate purposes. The financing is currently anticipated to be closed by November 26, 2020.

Khiron Life Sciences last traded at $0.55 on the TSX Venture.


FULL DISCLOSURE: Khiron Life Sciences is a former client of Canacom Group, the parent company of The Deep Dive. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Khiron Life Sciences Looks To Acquire PharmaDrug’s German Subsidiary For $2.0 Million

Khiron Life Sciences Corp. (TSXV: KHRN) announced today the plan to acquire Pharmadrug GmbH, a...

Tuesday, May 31, 2022, 10:34:00 AM

The Deep Dive Compiles Company Profile on Khiron Life Sciences

The Deep Dive has assembled a company profile for that of Khiron Life Sciences (TSXV:...

Sunday, May 31, 2020, 09:00:00 AM

Khiron Life Sciences Receives Authorization For The Sale Of High-CBD Medical Cannabis In Peru

Khiron Life Sciences (TSXV: KHRN) announced this morning that it now has access to yet...

Thursday, July 23, 2020, 08:59:43 AM

Khiron To Conduct Live Virtual Tour Of New Medical Facility On July 21

What do you do when your investors are located thousands of miles away from your...

Friday, July 17, 2020, 08:51:42 AM

Khiron Receives National Strategic Project Status From Colombian Government

This morning Khiron Life Sciences Corp (TSXV: KHRN) announced they received the status of National...

Tuesday, September 22, 2020, 09:43:55 AM